By the way, it doesn't support a theory that Novartis will jump into technology using EPGL patent. However, the right approach can save a lot of time and generate a huge pile of money by using others R&D such as EPGL.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.